Divided dose therapies with vascular damaging activity

Details for Australian Patent Application No. 2001242586 (hide)

Owner Angiogene Pharmaceuticals Ltd.

Inventors Davis, Peter David

Agent Davies Collison Cave

Pub. Number AU-B-2001242586

PCT Pub. Number WO01/74369

Priority 0014904 20.06.00 GB; 0013928 08.06.00 GB; 0007740 31.03.00 GB

Filing date 27 March 2001

Wipo publication date 15 October 2001

Acceptance publication date 16 December 2004

International Classifications

A61K 031/661 - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 035/00 Antineoplastic agents

Event Publications

16 December 2004 Application Accepted

  Published as AU-B-2001242586

14 April 2005 Standard Patent Sealed

15 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001242588-COMBINATION OF REBOXETINE AND CITALOPRAM

2001242584-Mixed reactant fuel cells